Cormorant Private Healthcare Fund II, LP
SEC CIK 1747677 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 10% | 8.49M | $3.52M | — | 1 | 2023-10-05 | 2023-10-05 |
Most active insiders at MLTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| 2 | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| 3 | Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| 4 | Reich Kristian | CSO | — | $8.14M |
| 5 | Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Cormorant Private Healthcare Fund II, LP made no open-market trades at MLTX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-10-10 | 2023-10-05 | MLTX | MoonLake Immunotherapeutics | Cormorant Private Healthcare Fund II, LP | 10% | P - Purchase | $59.90 | +58.8K | 8.49M | +0.7% | +$3.52M |
Purchase Sale Sale after option exercise All abbreviations